Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

Summary

The aim of this study is to investigate the safety and tolerability of trichostatin A in individuals with relapsed or refractory hematologic malignancies.

Timeline

Start

2018-09-27

Primary completion

2027-12

Completion

2027-12

Publications

• Dhingra N, Gupta V, Tyagi A, Agrawala PK, Gupta V. Trichostatin A ameliorated combined radiation and skin wound injury-induced mortality and hematopoietic suppression in a rat model. Int J Radiat Biol. 2025;101(9):952-972. doi: 10.1080/09553002.2025.2537211. Epub 2025 Aug 4.

Drugs

Indications